Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium vs Lidocaine Trigger Point Injections for Chronic Pelvic Pain
NCT02728037Phase 3Terminated
- Sponsor
- Queen's University
- Start
- Apr 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate in myofascial pelvic pain (MPP), sponsored by Queen's University. Started Apr 2016; status: terminated.
02
Drugs
magnesium sulfate
03
Conditions
myofascial pelvic pain (MPP)
Beyond the preview
Go deeper on NCT02728037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728037.